Latest Breaking News On - Life park venture fund - Page 1 : comparemela.com

Beijing BoomRay Pharma has completed a $43 million Series A funding to develop novel radionuclide drugs that integrate diagnosis and treatment. Read more here.

United kingdomUnited statesQilu pharmaStockhom bioinventGenor biopharmaBoomray pharmaCansino biologicsLife park venture fundResearch laboratoryInstitute of biotechnologyUbs agTeam of scientistsAcademy of military medical sciencesMicrobiology developmentScientific lab for medicineVernalis research